PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
Open Access
- 1 December 2009
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (12) , 3797-3806
Abstract
Cardiac complications are a common cause of death in individuals with the inherited multisystemic disease myotonic dystrophy type 1 (DM1). A characteristic molecular feature of DM1 is misregulated alternative splicing due to disrupted functioning of the splicing regulators muscleblind-like 1 (MBNL1) and CUG-binding protein 1 (CUGBP1). CUGBP1 is upregulated in DM1 due to PKC pathway activation and subsequent CUGBP1 protein hyperphosphorylation and stabilization. Here, we blocked PKC activity in a heart-specific DM1 mouse model to determine its pathogenic role in DM1. Animals given PKC inhibitors exhibited substantially increased survival that correlated with reduced phosphorylation and decreased steady-state levels of CUGBP1. Functional studies demonstrated that PKC inhibition ameliorated the cardiac conduction defects and contraction abnormalities found in this mouse model. The inhibitor also reduced misregulation of splicing events regulated by CUGBP1 but not those regulated by MBNL1, suggesting distinct roles for these proteins in DM1 cardiac pathogenesis. The PKC inhibitor did not reduce mortality in transgenic mice with heart-specific CUGBP1 upregulation, indicating that PKC inhibition did not have a general protective effect on PKC-independent CUGBP1 increase. Our results suggest that pharmacological blockade of PKC activity mitigates the DM1 cardiac phenotype and provide strong evidence for a role for the PKC pathway in DM1 pathogenesis.Keywords
This publication has 38 references indexed in Scilit:
- A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heartProceedings of the National Academy of Sciences, 2008
- Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillationHeart Rhythm, 2008
- Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1New England Journal of Medicine, 2008
- Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophyProceedings of the National Academy of Sciences, 2008
- RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expressionNature Genetics, 2007
- Inducible and myocyte-specific inhibition of PKCα enhances cardiac contractility and protects against infarction-induced heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Genetic Diseases of JunctionsJournal of Investigative Dermatology, 2007
- Increased Steady-State Levels of CUGBP1 in Myotonic Dystrophy 1 Are Due to PKC-Mediated HyperphosphorylationMolecular Cell, 2007
- Cardiovascular Manifestations of Myotonic Dystrophy-1Cardiology in Review, 2007
- Misregulation of Alternative Splicing Causes Pathogenesis in Myotonic Dystrophy2006